The combined effect of sidestream smoke and dynamic shear stress on endothelial cell inflammatory responses

Thrombosis Research

Volumn 135, Issue 2, 2015, Pages 362-367

  Yin, Wei ^a,b   Ngwe, Ek Ching ^b   Ghebrehiwet, Berhane ^c   Rubenstein, David A ^a  

^a St Francis Hospital The Heart Center   (United States)

^b Oklahoma State University   (United States)

^c STONY BROOK UNIVERSITY   (United States)

Author keywords

cC1qR; Complement activation; Endothelial cells; gC1qR; Shear stress; Sidestream smoke

Indexed keywords

CIGARETTE SMOKE; COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C1Q RECEPTOR; COMPLEMENT COMPONENT C1S INHIBITOR; COMPLEMENT COMPONENT C3B; COMPLEMENT COMPONENT C3B RECEPTOR; COMPLEMENT COMPONENT C4D; COMPLEMENT RECEPTOR; INTERCELLULAR ADHESION MOLECULE 1; SIDESTREAM SMOKE; THROMBOMODULIN; UNCLASSIFIED DRUG; PASSIVE SMOKING;

ARTICLE; CELL ACTIVATION; CELL DAMAGE; CELL SURFACE; COMPLEMENT ACTIVATION; COMPLEMENT CLASSICAL PATHWAY; COMPLEMENT FIXATION; COMPUTATIONAL FLUID DYNAMICS; CONTROLLED STUDY; CORONARY ARTERY; CORONARY ARTERY DISEASE; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IN VITRO STUDY; INFLAMMATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SHEAR STRESS; ADVERSE EFFECTS; IMMUNOLOGY; MECHANICAL STRESS; METABOLISM; PASSIVE SMOKING; PATHOLOGY; RISK FACTOR;

COMPLEMENT ACTIVATION; ENDOTHELIAL CELLS; HUMANS; RISK FACTORS; STRESS, MECHANICAL; TOBACCO SMOKE POLLUTION;

EID: 84921473135     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2014.11.018     Document Type: Article

References (43)

1. Richter D. Smoking: A deadly pleasant habit-is there a way out? Angiology 2008;59:49S-53S.
2. Penn A, Snyder CA. Inhalation of sidestream cigarette smoke accelerates development of arteriosclerotic plaques. Circulation 1993;88:1820-5.
3. Schick S, Glantz S. Philip morris toxicological experiments with fresh sidestream smoke: More toxic than mainstream smoke. Tob Control 2005;14:396-404.
4. Moir D, Rickert WS, Levasseur G, Larose Y, Maertens R, White P, et al. A comparison of mainstream and sidestream marijuana and tobacco cigarette smoke produced under two machine smoking conditions. Chem Res Toxicol 2008;21:494-502.
5. Barnoya J, Glantz SA. Cardiovascular effects of secondhand smoke: Nearly as large as smoking. Circulation 2005;111:2684-98.
6. Puranik R, Celermajer DS. Smoking and endothelial function. Prog Cardiovasc Dis 2003;45:443-58.
7. Cunningham KS, Gotlieb AI. The role of shear stress in the pathogenesis of atherosclerosis. Lab Investig 2005;85:9-23.
8. Lindemann S, Kramer B, Seizer P, Gawaz M. Platelets, inflammation and atherosclerosis. J Thromb Haemost 2007;5(Suppl. 1):203-11.
9. Gu L, Okada Y, Clinton SK, Gerard C, Sukhova GK, Libby P, et al. Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. Mol Cell 1998;2:275-81.
10. Malek AM, Jackman R, Rosenberg RD, Izumo S. Endothelial expression of thrombomodulin is reversibly regulated by fluid shear stress. Circ Res 1994;74:852-60.
11. Yin W, Ghebrehiwet B, Weksler B, Peerschke EI. Regulated complement deposition on the surface of human endothelial cells: Effect of tobacco smoke and shear stress. Thromb Res 2008;122:221-8.
12. Yin W, Ghebrehiwet B, Weksler B, Peerschke EI. Classical pathway complement activation on human endothelial cells. Mol Immunol 2007;44:2228-34.
13. Trouw LA, Blom AM, Gasque P. Role of complement and complement regulators in the removal of apoptotic cells. Mol Immunol 2008;45:1199-207.
14. Niculescu F, Rus H. The role of complement activation in atherosclerosis. Immunol Res 2004;30:73-80.
15. Seifert PS, Kazatchkine MD. The complement system in atherosclerosis. Atherosclerosis 1988;73:91-104.
16. Maresh JG, Xu H, Jiang N, Gairola CG, Shohet RV. Tobacco smoke dysregulates endothelial vasoregulatory transcripts in vivo. Physiol Genomics 2005;21:308-13.
17. Hasan M, Rubenstein DA, Yin W. Effects of cyclic motion on coronary blood flow. J Biomech Eng 2013;135:121002.
18. Shanmugavelayudam SK, Rubenstein DA, Yin W. Effect of geometrical assumptions on numerical modeling of coronary blood flow under normal and disease conditions. J Biomech Eng 2010;132:061004.
19. Rubenstein D, Jesty J, Bluestein D. Differences between mainstream and sidestream cigarette smoke extracts and nicotine in the activation of platelets under static and flow conditions. Circulation 2004;109:78-83.
20. Ghebrehiwet B, Lim BL, Kumar R, Feng X, Peerschke EI. Gc1q-r/p33, a member of a new class of multifunctional and multicompartmental cellular proteins, is involved in inflammation and infection. Immunol Rev 2001;180:65-77.
21. Ghebrehiwet B, Lu PD, Zhang W, Lim BL, Eggleton P, Leigh LE, et al. Identification of functional domains on gc1q-r, a cell surface protein that binds to the globular "heads" of c1q, using monoclonal antibodies and synthetic peptides. Hybridoma 1996;15:333-42.
22. Ghebrehiwet B, Peerschke EI. Cc1q-r (calreticulin) and gc1q-r/p33: Ubiquitously expressed multi-ligand binding cellular proteins involved in inflammation and infection. Mol Immunol 2004;41:173-83.
23. Yin W, Rouf F, Shanmugavelayudam S, Rubenstein D. Endothelial cells modulate platelet response to dynamic shear stress. Cardiovasc Eng Technol 2014;5(2):145-53.
24. Malek AM, Alper SL, Izumo S. Hemodynamic shear stress and its role in atherosclerosis. JAMA 1999;282:2035-42.
25. Gibson CM, Diaz L, Kandarpa K, Sacks FM, Pasternak RC, Sandor T, et al. Relation of vessel wall shear stress to atherosclerosis progression in human coronary arteries. Arterioscler Thromb 1993;13:310-5.
26. Schmaier AH, Murray SC, Heda GD, Farber A, Kuo A, McCrae K, et al. Synthesis and expression of c1 inhibitor by human umbilical vein endothelial cells. J Biol Chem 1989;264:18173-9.
27. Wagner C, Ochmann C, Schoels M, Giese T, Stegmaier S, Richter R, et al. The complement receptor 1, cr1 (cd35), mediates inhibitory signals in human t-lymphocytes. Mol Immunol 2006;43:643-51.
28. Peerschke EI, Bayer AS, Ghebrehiwet B, Xiong YQ. Gc1qr/p33 blockade reduces staphylococcus aureus colonization of target tissues in an animal model of infective endocarditis. Infect Immun 2006;74:4418-23.
29. Guarino F, Cantarella G, Caruso M, Russo C, Mancuso S, Arcidiacono G, et al. Endothelial activation and injury by cigarette smoke exposure. J Biol Regul Homeost Agents 2011;25:259-68.
30. Wang L, Wang H, Zhang X. effects of tobacco smoke on the expression of icam-1 in human umbilical vein endothelial cells. Zhonghua yu fang yi xue za zhi 2001;35:105-7.
31. Kew RR, Ghebrehiwet B, Janoff A. Cigarette smoke can activate the alternative pathway of complement in vitro by modifying the third component of complement. J Clin Invest 1985;75:1000-7.
32. Zou N, Hong J, Dai QY. Passive cigarette smoking induces inflammatory injury in human arterial walls. Chin Med J 2009;122:444-8.
33. Chatzizisis YS, Coskun AU, Jonas M, Edelman ER, Feldman CL, Stone PH. Role of endothelial shear stress in the natural history of coronary atherosclerosis and vascular remodeling: Molecular, cellular, and vascular behavior. J Am Coll Cardiol 2007;49: 2379-93.
34. Traub O, Berk BC. Laminar shear stress: Mechanisms by which endothelial cells transduce an atheroprotective force. Arterioscler Thromb Vasc Biol 1998;18:677-85.
35. Spivia W, Magno PS, Le P, Fraser DA. Complement protein c1q promotes macrophage anti-inflammatory m2-like polarization during the clearance of atherogenic lipoproteins. Inflamm Res 2014;63(10):885-93.
36. Fraser DA, Tenner AJ. Innate immune proteins c1q and mannan-binding lectin enhance clearance of atherogenic lipoproteins by human monocytes and macrophages. J Immunol 2010;185:3932-9 [Baltimore, Md: 1950].
37. Fraser DA, Pisalyaput K, Tenner AJ. C1q enhances microglial clearance of apoptotic neurons and neuronal blebs, and modulates subsequent inflammatory cytokine production. J Neurochem 2010;112:733-43.
38. Hertle E, Stehouwer CDA, van Greevenbroek MMJ. The complement system in human cardiometabolic disease. Molecular immunology 2014;61(2):135-48.
39. Ghebrehiwet B, Jesty J, Peerschke EI. Gc1q-r/p33: Structure-function predictions from the crystal structure. Immunobiology 2002;205:421-32.
40. Bohlson SS, Fraser DA, Tenner AJ. Complement proteins c1q and mbl are pattern recognition molecules that signal immediate and long-term protective immune functions. Mol Immunol 2007;44:33-43.
41. Walport MJ. Complement and systemic lupus erythematosus. Arthritis Res 2002;4(Suppl. 3):S279-93.
42. Mitchell DA, Pickering MC, Warren J, Fossati-Jimack L, Cortes-Hernandez J, Cook HT, et al. C1q deficiency and autoimmunity: The effects of genetic background on disease expression. J Immunol 2002;168:2538-43 [Baltimore, Md: 1950].
43. van den Berg RH, Faber-Krol MC, Sim RB, Daha MR. The first subcomponent of complement, c1q, triggers the production of il-8, il-6, and monocyte chemoattractant peptide-1 by human umbilical vein endothelial cells. J Immunol 1998;161: 6924-30 [Baltimore, Md: 1950].